利用药物基因组学结果指导抗抑郁药的选择:一个案例报告
Nicholas Vernacchia1, Nicole Del Toro-Pagán1, Chandni Bardolia1
11 Office of Translational Research and Residency Programs, Tabula Rasa HealthCare, Moorestown, New Jersey.
The Senior care pharmacist
|March 26, 2024
概括
药基因组 (PGx) 测试可以指导主要抑郁症患者选择抗抑郁药. 这种方法通过考虑遗传变异来改善治疗反应并最大限度地减少不良事件.
科学领域:
- 药物基因组学 药物基因组学
- 精神病学是一个精神病学.
- 临床药房 临床药房
背景情况:
- 大型抑郁症 (MDD) 影响着数以百万计的患者,近一半的患者经历了初始抗抑郁药疗法的治疗失败.
- 患者对抗抑郁药的可变反应通常与代谢酶的遗传变异有关.
- 药基因组 (PGx) 测试提供了一个个性化的方法来优化抗抑郁药的选择和改善治疗结果.
研究的目的:
- 为了证明PGx测试在指导患者选择抗抑郁药的临床实用性,患者对埃斯基塔洛普拉姆的反应不佳.
- 突出PGx结果如何为治疗决策提供信息,并改善MDD患者的治疗结果.
主要方法:
- 一个79岁的患有MDD的女性患者的案例研究,以及对埃斯基塔洛普拉姆 (escitalopram) 的次优反应史.
- 药物遗传学 (PGx) 咨询,以评估药物-基因,药物-药物和药物-药物-基因相互作用.
- 临床药剂师的干预建议基于PGx结果的替代抗抑郁药物治疗.
主要成果:
- 尽管在三年内增加了剂量,但该患者对埃斯基塔洛普拉姆的反应仍然不够好.
- PGx测试发现了潜在的药物基因相互作用,影响了埃斯基塔洛普拉姆代谢和疗效.
- 根据PGx结果指导的替代抗抑郁药疗法导致了显著的情绪改善.
结论:
- 药物基因组 (PGx) 测试是个性化抗抑郁药物治疗MDD患者的宝贵工具.
- 将PGx信息整合到临床实践中可以提高治疗选择,改善患者的反应,并减少不良事件.
- 这一案例强调了PGx在优化药物治疗中对挑战治疗抑郁症的好处.
相关概念视频
Antidepressant Drugs: Overview
467
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
467
Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
Human Genetics
566
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
566
Psychosis: Goals of Pharmacotherapy
125
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
125
G-protein Coupled Receptors
118.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.6K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
382
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
382


